Policy and Capital Fuel Accelerated Breakthrough in China’s Innovative Drug Industry
Bolstered by dual drivers of policy support and capital influx, China’s innovative drug industry is…
News
The Fda Anticipates Approving Five New Drugs By October 2025
The Prescription Drug User Fee Act (PDUFA) date marks the deadline by which the U.S.…
New Hope in Fighting Breast Cancer: Understanding the Targeted Drug Verzenio (Abemaciclib)
Verzenio has opened a new window of hope for many patients with HR-positive, HER2-negative breast…
Is Melanoma Cancer Curable? 5 Powerful Facts for Hopeful Recovery
Melanoma cancer is a type of skin cancer that begins in the pigment-producing cells called…
Busting the “Lazy Cancer” Myth: China Launches Thyroid Cancer Awareness Day for Full-Cycle Care
Thyroid cancer is now the focus of a newly established national awareness day in China,…
How Bad Is Lymphoma Cancer? 5 Powerful Steps for Early Action
Lymphoma cancer is a type of cancer that begins in the lymphatic system, where abnormal…
Drug Update | Global New Drug Approvals (Sep 1–5, 2025)
DengYueMed reports the latest developments in global new drug approvals and submissions for early September…
Prostate Cancer Warning Signs: 5 Symptoms Every Man Should Know
Prostate cancer is the second most common cancer in men worldwide; it has become something…
Soaring 148%! China Medical Achieves Major Breakthrough with 39 Class-1 Innovative Drugs and 12 Poised for Approval
Source: Dengyuemed | September 27, 2025 | Category: Pharmaceuticals As a Hong Kong drug wholesale…
Latest FDA Decisions Expected in September 2025: Five Innovative Therapies Under Review
In 2024, the U.S. FDA approved more than 60 innovative therapies and vaccines, highlighting a…